The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,952.00
Ask: 1,954.00
Change: 20.00 (1.03%)
Spread: 2.00 (0.102%)
Open: 1,940.00
High: 1,971.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 28th Feb 2013 07:19

AZ Electronic Materials: Goldman Sachs moves target price from 440p to 450p and retains a buy recommendation.Bovis Homes Group: Deutsche Bank shifts target price from 667p to 679p, while downgrading to hold.British American Tabacco: Investec places its target price (previously 3350p) and buy recommendation under review.Croda International: Goldman Sachs raises target price from 3150p to 3200p still recommending strong buying.Elementis: Goldman Sachs revises target price from 255p to 265p, while its neutral rating remains unchanged.Eurasian Natural Resources: Deutsche Bank lowers target price from 562p to 550p and stays with its buy recommendation.Genel Energy: Investec reduces target price from 1104p to 1000p keeping its buy recommendation.Gooch & Housego: N+1 Singer raises target price from 470p to 515p and upgrades to buy.Hays: Jefferies takes target price from 105p to 115p and reiterates its buy recommendation.Henderson Group: Morgan Stanley cuts target price from 160p to 154p, while retaining an equal-weight rating. UBS downgrades to neutral with a target price of 158p. Barclays lowers target price from 153p to 145p and reiterates an underweight rating. JP Morgan raises target price from 162p to 183p and maintains its neutral rating.Hikma: Panmure Gordon raises target price from 825p to 930p, while staying with its buy recommendation.Interserve: JP Morgan increases target price from 466p to 532p reiterating an overweight rating.Intu Properties: Jefferies lowers target price from 335p to 310p maintaining a hold recommendation. Deutsche Bank reduces target price from 480p to 410p and keeps its buy rating.ITV: Deutsche Bank ups target price from 90p to 100p, but still recommends selling. UBS raises target price from 90p to 115p and retains an equal-weight rating. Westhouse Securities increases target price from 133p to 141p and upgrades from add to buy. Investec shifts target price from 100p to 110p and upgrades from sell to hold. JP Morgan shifts target price from 120p to 126p, while its neutral rating remains unchanged. Panmure Gordon ups target price from 140p to 180p leaving its buy recommendation unaltered.LSL Property Services: Panmure Gordon ups target price from 287p to 337p and retains a buy recommendation.Petrofac: Morgan Stanley reduces target price from 2300p to 2100p, while leaving its overweight rating unchanged. Nomura downgrades target price from 1830p to 1740p reiterating a buy recommendation. Barclays cuts target price from 1900p to 1800p and reiterates an underweight rating.Promethean: JP Morgan shifts target price from 20p to 22p and leaves its neutral rating unchanged.Restaurant Group: Barclays takes target price from 400p to 460p, while staying with its overweight rating.Segro: Jefferies moves target price from 228p to 238p and keeps a hold recommendation.Severfield-Rowen: Canaccord Genuity reduces target price from 50p to 37p, while its sell recommendation is kept.Shire: Nomura cuts target price from 2300p to 2160p and downgrades from buy to neutral.Spirent Communications: Canaccord Genuity reduces target price from 180p to 156p downgrading from buy to hold. Panmure Gordon shifts target price from 192p to 191p and reiterates a buy recommendation.Standard Life: Credit Suisse shifts target price from 315p to 321p and keeps its underperform rating.St. James's Place: Investec places its target price (previously 472p) and buy recommendation under review.Synthomer: Goldman Sachs raises target price from 195p to 230p, while maintaining a neutral rating.United Carpets: After having had its target price under review, Cantor Fitzgerald places it at 2.5p and retains a hold recommendation.Victrex: Goldman Sachs increases target price from 1775p to 1850p reiterating a buy rating.Vitec Group: Investec moves target price from 700p to 740p and retains a buy recommendation.Weir Group: JP Morgan raises target price from 2500p to 2600p, while its overweight rating remains unchanged.Whitbread: Nomura ups target price from 2650p to 2968p and leaves its buy recommendation unaltered.Xchanging: Cantor Fitzgerald raises target price from 120p to 145p upgrading from hold to buy.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.